MNKD (MannKind Corporation) Utang jangka cendhak marang modal
MannKind Corporation (MNKD) operates its own US-based manufacturing facility to produce innovative drug delivery systems and inhalers. The business monetizes its unique Technosphere platform through licensing agreements with industry behemoths and the development of orphan drugs. This price chart featuring the 0.00 indicator confirms growth potential amid rising demand for convenient therapies for diabetes and pulmonary pathologies.
Rincian analitis perusahaan MannKind Corporation
- kuotasi lan prakiraan analis:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal MannKind Corporation|MNKD - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas MannKind|MNKD - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku MannKind Corp|MNKD - Utang jangka dawa|Kewajiban jangka cendhak perusahaan MannKind|Rasio cepet mannkindcorp.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Pambiji fundamental:MNKD MannKind Corp.
For MannKind Corporation (MNKD), the current short-term debt-to-equity chart reflects the dependence of inhaler supplies on operational liquidity amid geopolitical instability and logistics disruptions. The ratio of liabilities maturing within one year to equity measures the risk of excessive reliance on "fast" leverage, allowing investors to assess the resilience of the company's balance sheet to a sudden contraction of sales markets.
Pesaing MannKind Corporation (MNKD)
Utang jangka cendhak marang modal HLN|KVUE (Kenvue Health) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal VRNA (Verona Pharma plc)|Utang jangka cendhak marang modal jyongbio.com MENS|LGND - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal glpg.com|Rasio utang jangka cendhak marang ekuitas ANIP (ANI Pharmaceuticals, Inc.)|AMPH (Amphastar Pharmaceuticals Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Pacira PCRX|ARS Corp (SPRY) - Kewajiban jangka cendhak marang modal|TBPH: Rasio utang jangka cendhak marang ekuitas|aquestive.com - Rasio silihan jangka cendhak marang modal|SCPH: Utang jangka cendhak marang modal|Tectonic Therapeutic - Rasio tanggungan utang jangka cendhak marang modal|TNXP (Tonix Pharmaceuticals Inc.) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal SXT China SXTC|Utang jangka cendhak marang ekuitas Eupraxia Pharmaceuticals (EPRX)|BHST (bioharvest.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas eXoZymes EXOZ|ORMP - Rasio utang jangka cendhak marang ekuitas|Entera Bio Corp - Utang jangka cendhak marang modal|HYFT - Utang jangka cendhak marang modal|ABVC BioPharma (ABVC) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal CPIX|Utang jangka cendhak marang ekuitas Quantum BioPharma|Rasio utang jangka cendhak marang modal FGEN (FibroGen Inc)|Utang jangka cendhak marang ekuitas Telomir Pharma (TELO)|Utang jangka cendhak marang modal ranitherapeutics.com (RANI)|Utang jangka cendhak marang modal SNYR (Synergy CHC)|Koefisien utang jangka cendhak marang modal Rallybio Corp (RLYB)|LEXX - Utang jangka cendhak marang ekuitas|PULM (Pulmatrix Inc) - Rasio utang jangka cendhak marang modal|PTHL: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal APM|Rasio utang jangka cendhak marang ekuitas LYRA|IBO: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal TNFA|Rasio utang jangka cendhak marang ekuitas cbdmd.com YCBD|Utang jangka cendhak marang ekuitas PainReform Limited PRFX|Altamira Therapeutics Ltd (CYTO) - Kewajiban jangka cendhak marang modal|LIPO - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal OPTN (optinose.com)|Pieris Pharmaceuticals, Inc. (PIRS) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas PROC (Procaps Group)|Utang jangka cendhak marang ekuitas Petros|Kewajiban jangka cendhak marang modal Qilian International Corp QLI|Utang jangka cendhak marang ekuitas Acelyrin, Inc. (SLRN)|TFFP (tffpharma.com) - Rasio tanggungan utang jangka cendhak marang modal